Market Analysis
Suresh Vatsyayann
Abstract
The global market for interventional cardiology technologies reached an estimated $12.2 billion in 2014. According to a new study by Smithers Apex – The Future of Coronary Artery Disease Medical Devices to 2021 – it will grow to $22.5 billion (€20.9 billion) by 2021, with a year-on-year increase of 9.1%. Demand for coronary artery disease medical devices will grow through 2021 as clinically viable and cost-effective solutions are developed. The report covers three major segments of cardiology surgery, devices and drugs market which includes surgeries, devices and drugs. Cardiovascular diseases are the number one cause of death globally. Some of the major CVDs include coronary heart diseases, , stroke, hypertensive heart diseases, inflammatory heart diseases, rheumatoid heart diseases and others. Coronary heart diseases are the leading cause of death followed by strokes. The prevalence and incidence rate of heart diseases are on a rise; especially in major emerging countries such as India, China and Japan. The market of cardiology surgery, devices and drugs are also on a rise.